| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.072 | 0.6 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |